BeOne Medicines Ltd. (ONC) stock
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302571% above fair value
$403.60−9.66 (-2.34%)
Close on Nov 18, 2026Market cap $45.89BP/E 72.2Yield –
BeOne Medicines pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
BeOne Medicines's pe ratio was 75.1× on Nov 11, 2026, against 873.4× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 75.1× | −703.9 |
| 2025 | Dec 31, 2025 | 779.0× | – |
See a number that looks wrong?